3
In our previous studies on arylation of naphthoquinones it has
been proved, through radical trapping experiments, that the
combination of arylhydrazine and IBX generates aryl free
radicals.14-15 On the same lines we postulate cyclohexyl free
radical mediated mechanism for the reaction leading to formation
of 1 (Scheme 4). Attack of cyclohexylhydrazine on electrophilic
iodine of IBX would form intermediate B which on redox
decomposition may form cyclohexyldiazine 12 and
o-iodosobenzoic acid (IBA). Further highly nucleophilic 12
would attack on another molecule of IBX forming an
intermediate C. Intermediate C on oxidative extrusion of
nitrogen would leave behind two free radical species A and D by
single electron transfer mechanism demonstrated by Nicolaou et
al.17 Cyclohexyl free radical A would then attack on unsubstituted
electrophilic position of corresponding quinoid ring of 3 to form
1 after removal of water molecule presumed through interaction
of free radical intermediates E and D. Observance of evolution of
nitrogen gas during the course of reaction and recovery of IBA as
a by-product are found supportive toward the postulated radical
mediated mechanism.
In conclusion, we have established a novel protocol for
generation of cyclohexyl free radical alongside a new, mild, and
single step method for synthesis of parvaquone. This new method
could be considered as competent alternative to the previously
reported free radical based methods as it circumvent toxic
transition metals, hazardous peroxides, high temperature and
longer reaction time. We believe that the developed method
could be considered as valuable entry not only for parvaquone
but also toward exploration of synthesis of other similar
molecules through combination of appropriate hydrazines and
IBX. A free radical mediated mechanism is postulated for the
reaction based on observations and previously established IBX
chemistry.
TLC (using mobile phase, hexane: ethyl acetate/5:95). After
satisfactory TLC, water (20 mL) was added to the reaction
mixture and acetonitrile was evaporated using rotary evaporator.
To the residue obtained was added dichloromethane (30 mL).
Oganic layer was separated and washed with saturated sodium
bicarbonate solution followed by saturated solution of sodium
sulphite. Separated organic layer was dried over anhydrous
sodium sulphate and evaporated to obtain crude 1 which was
further purified by column chromatography (mobile phase -
hexane: ethyl acetate/5:95) to afford 1 as yellow solid, (0.88 g,
60% yield); mp 136-138 °C (lit.18 135-136°C); FT-IR (KBr):
3585, 3513, 3071, 2926, 2853, 1666, 1604, 1590 cm-1; 1H NMR
(300 MHz; CDCl3): δ 1H NMR (400 MHz, CDCl3): δ 8.17-7.96 (m,
2H), 7.82-7.59 (m, 2H), 7.34 (s, 1H, OH), 3.22-2.85 (m, 1H), 1.85-
1.12 (m, 10H) ppm; 13C NMR (75 MHz; CDCl3): δ 184.5, 181.9,
152.8, 135.1, 134.9, 132.7, 129.2, 127.9, 126.9, 125.9, 35.1, 29.2,
26.7, 25.9.
Synthesis of 2-amino-3-cyclohexyl-1,4-naphthoquinone (11):
Above mentioned procedure for synthesis of 1 was similarly
followed for synthesis of 11 by using 10 (1.0 g, 5.77 mmol), IBX
(3.87 g, 13.8 mmol) and cyclohexylhydrazine (0.79 g, 6.92
mmol) to provide 11 as orange red solid, (0.85 g, 58% yield); mp
125-128 °C; FT-IR (KBr): 3466, 3372, 3071, 2926, 2853, 1666,
1604, 1575, 1446, 1384 and 1282 cm-1; H NMR (300 MHz;
1
CDCl3): δ 8.05-7.98 (dd, J = 21 Hz, 2H), 7.67-7.58 (dd, J = 27
Hz, 2H), 5.24 (s, broad, 2H), 2.78 (m, 1H), 1.93-1.34 (m, 10H);
13C NMR (75 MHz; CDCl3): δ 182.6, 181.8, 144.3, 134.0, 133.2,
131.6, 129.9, 126.0, 125.3, 120.4, 36.4, 29.0, 26.8, 25.8; Anal.
Calcd for C16H17NO2: C, 75.33; H, 6.68; N, 5.45; Found: C,
75.29; H, 6.66; N, 5.49.
References and notes
1. (a) Patai S. In: Rappoport Z, ed. The Chemistry of Quinonoid
Compounds, Vol 2. Wiley, New York 1988: Parts 1 and 2; (b)
Thomson RH. In: Naturally Occuring Quinones IV, Blackie
Academic, London 1997; (c) Puder C, Wagner K, Vettermann R,
Hauptmann R, Potterat O. J Nat Prod. 2005; 68: 323-326; (d)
Zhang B, Salituro G, Szalkowski D, Li Z, Zhang Y, Royo I,
Vilella D, Diez MT, Pelaez F, Ruby C, Kendall RL, Mao X,
Griffin P, Cataycay J, Zierath JR, Heck JV, Smith RG, Moller DE.
Science 1999; 284: 974; (e) Yun B-S, Lee I-K, Kim J-P, Yoo I-D.
J Antibiot. 2000; 53: 114.
Acknowledgements: We are thankful to TEQIP (Technical
Education Quality Improvement Program) for providing financial
support to this work.
Supplementary Material: 1H NMR for compound 1 and 1H, 13C
NMR spectra for compound 11 are can be found, in the online
2. (a) Spyroudis S. Molecules 2000; 5: 1291 and references cited
therein; (b) Finefield JM, Sherman DH, Kreitman M, Williams
RM. Angew Chem Int Ed. 2012; 51: 4802; (c) Baramee A, Coppin
A, Mortuaire M, Pelinski L, Tomavoc S, Brocard J. Bioorg Med
Chem. 2006; 14: 1294; (d) Solorio-Alvarado CR, Peña-Cabrera E,
García-Soto J, LópezGodínez J, González FJ, Álvarez-Hernández
A. Arkivoc 2009 (ii); 239 and references cited therein; (e) Croft
Note: *Corresponding author: Pravin C Patil. Tel: +91-22-3361102.
Email: pravinchem@gmail.com.
Experimental
General Methods: Commercial grade solvents and reagents were
used without further purification. Silica gel-G plates (Merck)
were used for TLC analysis. Column chromatography was
carried out using silica gel 60 (70-230 mesh. Nuclear magnetic
resonance (1H and l3C NMR) spectra were recorded with Bruker
300 MHz and 400 MHz instrument using CDCl3 as a solvent and
TMS as internal standard. Infrared spectra were recorded with a
Perkin-Elmer spectrum 100 instrument.
SL, Hogg J, Gutteridge WE, Hudson AT, Randall AW.
J
Antimicrob Chem 1992; 30: 827; (f) Schuck DC, Ferreira SB,
Cruz LN, Rocha DR, Moraes MS, Nakabashi M, Rosenthal PJ,
Ferreira VF, Garcia CR.-S. Malaria Journal 2013; 12: 234;
(g) Hussain H, Krohn K, Ahmad VU, Miana GA, Green IR.
Arkivoc 2007 (ii); 145; (h) Mantyla A, Garnier T, Rautio J,
Nevalainen T, Vepsaelainen J, Koskinen A, Croft SL, Jarvinen T.
J Med Chem 2004; 47: 188.
3. Fieser LF, Leffler MT. US Patent 2553648 (1951); Chem. Abs.
1952:2859.
4. (a) Hashemi-Fesharki R. Res Vet Sci.1991; 50: 204; (b) Dolan TT,
Young AS, Leitch BL, Stagg DA. Vet Parasitol. 1984; 15: 103;
(c) Unsuren H, Kurtdede A, Goksu K. Trop Anim Hlth Prod.
1988; 20: 256; (d) Hawa N, Rae DG, Younis S, Mahadi W,
Ibrahim R, Al-Wahab W. Trop Anim Hlth Prod. 1988; 20: 130.
5. (a) Hughes W, Leoung G, Kramer F, Bozzette SA, Safrin S,
Frame P, Clumeck N, Masur H, Lancaster D, Chan C, Lavelle J,
Rosenstock J, Falloon J, Feinberg J, Lafon S, Rogers M, Sattler F.
N Engl J Med. 1993; 328: 1521; (b) Dohn MN, Weinberg WG,
Torres RA, Follansbee SE, Caldwell PT, Scott JD, Gathe JC,
Haghighat DP, Sampson JH, Spotkov J, Deresinski SC, Meyer
RD, Lancaster DJ. Ann Intern Med. 1994; 121: 174; (c) Cirioni O,
Typical procedure and characterization data for compound 1
and 10:
Synthesis
of
2-cyclohexyl-3-hydroxy-1,4-naphthoquinone
(parvaquone) (1): To a solution of 3 (1.0 g, 5.74 mmol) in
acetonitrile (20 mL) was added IBX (3.80 g, 13.6 mmol) in one
lot and stirred for 5 min at room temperature. To this was added
dropwise a solution of 8 (0.78 g, 6.8 mmol) dissolved in 10 mL
of acetonitrile over the course of 20 min. During the addition of 8
exotherm (up to 35 °C) was observed with evolution of nitrogen
gas in the form of bubbles. Reaction progress was monitored by
Giancometti A, Balducci M, Burzacchini F, Scalise FG.
J
Antimicrob Chemother. 1995; 36: 740; (d) Comley JCW, Yeates C
L, Frend TJ. Antimicrob Agents Chemother. 1995; 39: 2217.